Sichuan Yuanda Shuyang Pharmaceut.
Sichuan Yuanda Shuyang Pharmaceutical Co
Ltd (Shuyang) was founded in 1985 and now is a subsidiary of China Grand
Enterprises, Inc. The total asset of
Shuyang is more than 1.5 billion Yuan, with 1.5 billion Yuan of annual sales
revenue in 2018. The company has 17
subsidiary plasmapheresis centers. The
products are selling all over the country and already entering into
international market for 15 years. Shuyang is a leading company for exportation
of blood products in China.
Shuyang was among the first batch of blood products manufacturers which passed both GMP and ISO 9001 quality certification in China, and was also the first one who simultaneously passed verification of Quality (ISO9001), Environment (ISO14001) and Occupational Health systems (OHSAS18001) in China. Shuyang has gotten GMP approval by international inspections from Russia and Turkey etc, and many products have registered in Europe, Asia and South American countries.
Shuyang's main products include: Human Albumin, Human Immunoglobulin(pH4) for Intravenous Injection (IVIG), Human Hepatitis B Immunoglobulin(pH4) for Intravenous Injection, Human Hepatitis B Immunoglobulin, Human Tetanus Immunoglobulin, Human Rabies Immunoglobulin, Human Immunoglobulin for Intramuscular Injection, Human Histamine Immunogobulin.
It is Shuyang's strategy to meet international standards, to utilize more plasma sources, and to develop the company in the overall bio-pharmaceutical field. Shuyang will take plasma products as the basis of its further development and build up additional biomedical products, and will become one of the largest bio-pharmaceutical manufacturer in China having the capability to compete in the international market. Shuyang will have further rapid and healthy growth.
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||Biomanufacturing |Biopharmaceuticals (general category) |Immunology More|
CPhI Worldwide 20195-7 November 2019 Frankfurt, Germany We were at stand 91G02 See our Exhibitor Profile See full Exhibitor List
CPhI Worldwide 20189 - 11 October 2018 Madrid, Spain We were at stand 14.0H11 See our Exhibitor Profile See full Exhibitor List
Our Top products
The main component of this preparation is human albumin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process of human albumin contains a step of heating the final solution at 60℃ for 10 hours to inactivate the viruses present in it. It contains a ...More info
Human Hepatitis B Immunoglobulin
The manufacturing process for human hepatitis B
immunoglobulin contains a step of low pH incubation for viral inactivation. It
contains a suitable amount of glycine as stabilizer, but does not contain any
antiseptic or antibiotic.
-Post-exposure prophylaxis should be cons...
Human Hepstitis B Immunoglobulin (Ph4) For Intrevenous Injection
constituent: Human hepatitis B immunoglobulin; Subsidiary material: Maltose
Indications:Use of the product in combination with lamivudine can prevent patients with HBV (hepatitis B virus)-related diseases from being re-infected with HBV after liver transplantation.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation